Overview
Acadia Healthcare Company, Inc., based in the United States, operates as a leading provider in the behavioral healthcare industry. The company specializes in delivering psychiatric and chemical dependency services through a network extending to over 220 facilities across the United States and Puerto Rico. Acadia’s services are comprehensive, encompassing inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. Acadia Healthcare focuses on creating tailored treatment programs that address a wide spectrum of mental health conditions and substance abuse issues, striving to meet the diverse needs of its patient population. Through strategic acquisitions and expansions, Acadia significantly enhances its service portfolio, emphasizing the development of innovative treatment modalities and accessibility to high-quality care.
AI+ Ask Fintel’s AI assistant about Acadia Healthcare Company, Inc..
Thinking about good questions…
Basic Stats
The share price of Acadia Healthcare Company, Inc. as of September 5, 2025 is €19.70 / share. This is a decrease of 0.00% from the prior week. The market cap (or net worth) of Acadia Healthcare Company, Inc. as of September 5, 2025 is €1,780.76 MM.
The Factor Analysis chart (below right) shows a view of Acadia Healthcare Company, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 1,780.76 MM |
| EV | |
| Shares Out. | 90.39 MM |
| Earnings Date | |
| EPS (TTM) | 1.54 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | 0.20 |
| Beta | 2.39 |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.02 |
| ROE | 0.05 |
| ROIC | 0.02 |
| CROIC | 0.01 |
| OCROIC | 0.08 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 54.14 /100 |
| Profitability | 53.05 /100 |
| Quality Score | 69.25 /100 |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | 88.27 /100 |
| Analyst Sentiment | |
| Fund Sentiment | 13.35 /100 |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 5.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Acadia Healthcare Company, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2025-08-13 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-08-14 | Raymond James | Strong Buy | Outperform | Downgrade |
| 2025-08-14 | Mizuho | Neutral | Neutral | Maintains |
| 2025-05-14 | Mizuho | Neutral | Neutral | Maintains |
| 2025-05-14 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-04-09 | Guggenheim | Buy | Initiate | |
| 2025-03-25 | Mizuho | Neutral | Neutral | Maintains |
| 2025-03-03 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-03-03 | Keybanc | Overweight | Overweight | Maintains |
| 2025-02-28 | Barclays | Overweight | Equal-Weight | Downgrade |
| 2025-02-28 | B of A Securities | Buy | Buy | Maintains |
| 2025-01-10 | RBC Capital | Outperform | Outperform | Reiterate |
| 2025-01-07 | TD Cowen | Buy | Buy | Maintains |
| 2025-01-07 | Keybanc | Sector Weight | Overweight | Upgrade |
| 2024-12-12 | Deutsche Bank | Hold | Buy | Upgrade |
| 2024-12-10 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-11-22 | Barclays | Overweight | Overweight | Maintains |
| 2024-11-18 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-10-11 | Keybanc | Sector Weight | Initiate | |
| 2024-10-04 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-10-01 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-09-30 | Barclays | Overweight | Overweight | Maintains |
| 2024-09-20 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-08-20 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-08-19 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-08-02 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-08-02 | Deutsche Bank | Hold | Hold | Maintains |
| 2024-08-01 | Barclays | Overweight | Overweight | Maintains |
| 2024-08-01 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-07-10 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-07-09 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-07-02 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-05-22 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-05-17 | TD Cowen | Buy | Buy | Maintains |
| 2024-05-15 | Barclays | Overweight | Overweight | Maintains |
| 2024-05-03 | Mizuho | Neutral | Neutral | Maintains |
| 2024-05-02 | B of A Securities | Buy | Buy | Maintains |
| 2024-05-02 | Barclays | Overweight | Overweight | Maintains |
| 2024-04-25 | Deutsche Bank | Sell | Hold | Upgrade |
| 2024-03-06 | Mizuho | Neutral | Neutral | Maintains |
| 2024-03-06 | Barclays | Overweight | Initiate | |
| 2024-03-05 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-03-04 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-03-01 | TD Cowen | Outperform | Outperform | Maintains |
| 2024-02-28 | UBS | Buy | Buy | Maintains |
| 2024-01-05 | Stephens & Co. | Equal-Weight | Overweight | Upgrade |
| 2023-11-07 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-09-14 | Cantor Fitzgerald | Neutral | Neutral | Maintains |
| 2023-07-31 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-07-31 | Credit Suisse | Outperform | Outperform | Reiterate |
| 2023-07-12 | Stephens & Co. | Equal-Weight | Equal-Weight | Reiterate |
| 2023-06-02 | Stephens & Co. | Equal-Weight | Equal-Weight | Reiterate |
| 2023-05-04 | Credit Suisse | Outperform | Maintains | |
| 2023-04-28 | Credit Suisse | Outperform | Maintains | |
| 2023-04-27 | Stephens & Co. | Equal-Weight | Reiterate | |
| 2023-04-24 | UBS | Buy | Maintains | |
| 2023-04-20 | Deutsche Bank | Hold | Sell | Downgrade |
| 2023-03-06 | Deutsche Bank | Hold | Maintains | |
| 2023-03-06 | Mizuho | Neutral | Maintains | |
| 2023-03-01 | Stephens & Co. | Equal-Weight | Maintains | |
| 2023-02-28 | Stephens & Co. | Equal-Weight | Reiterate | |
| 2022-12-12 | RBC Capital | Outperform | Maintains | |
| 2022-12-12 | Loop Capital | Hold | Buy | Upgrade |
| 2022-12-08 | Mizuho | Neutral | Maintains | |
| 2022-12-08 | Stephens & Co. | Equal-Weight | Maintains | |
| 2022-11-02 | Stephens & Co. | Equal-Weight | Maintains | |
| 2022-11-02 | Mizuho | Neutral | Maintains | |
| 2022-08-26 | SVB Leerink | Outperform | Maintains | |
| 2022-08-01 | RBC Capital | Outperform | Maintains | |
| 2022-08-01 | Raymond James | Strong Buy | Maintains | |
| 2022-07-29 | Mizuho | Neutral | Maintains | |
| 2022-07-29 | Barclays | Underweight | Maintains | |
| 2022-07-28 | UBS | Buy | Maintains | |
| 2022-06-17 | Loop Capital | Hold | Initiate | |
| 2022-05-05 | SVB Leerink | Outperform | Maintains | |
| 2022-05-05 | Raymond James | Strong Buy | Maintains | |
| 2022-04-08 | SVB Leerink | Outperform | Maintains | |
| 2022-03-02 | Credit Suisse | Outperform | Maintains | |
| 2022-03-01 | SVB Leerink | Outperform | Maintains | |
| 2021-11-01 | Credit Suisse | Outperform | Maintains | |
| 2021-09-27 | SVB Leerink | Outperform | Initiate | |
| 2021-09-24 | UBS | Buy | Initiate | |
| 2021-09-20 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2021-09-10 | Cowen & Co. | Outperform | Initiate | |
| 2021-08-12 | Barclays | Underweight | Initiate | |
| 2021-08-04 | Credit Suisse | Neutral | Maintains | |
| 2021-07-09 | Seaport Global | Neutral | Initiate | |
| 2021-05-03 | Credit Suisse | Neutral | Maintains | |
| 2021-05-03 | Raymond James | Strong Buy | Maintains | |
| 2021-03-01 | Credit Suisse | Neutral | Maintains | |
| 2021-03-01 | Raymond James | Strong Buy | Maintains | |
| 2020-11-02 | Credit Suisse | Neutral | Maintains | |
| 2020-11-02 | Mizuho | Neutral | Maintains | |
| 2020-09-30 | Raymond James | Outperform | Strong Buy | Upgrade |
| 2020-08-06 | Credit Suisse | Neutral | Maintains | |
| 2020-05-07 | Deutsche Bank | Hold | Maintains | |
| 2020-05-06 | Baird | Neutral | Maintains | |
| 2020-05-06 | Credit Suisse | Neutral | Maintains | |
| 2020-05-06 | Raymond James | Outperform | Reiterate | |
| 2019-12-11 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
| 2019-09-20 | UBS | Neutral | Maintains | |
| 2019-09-06 | UBS | Neutral | Maintains | |
| 2019-07-31 | Raymond James | Strong Buy | Outperform | Downgrade |
| 2019-05-01 | BMO Capital | Market Perform | Market Perform | Maintains |
| 2019-03-04 | Baird | Neutral | Neutral | Maintains |
| 2019-03-04 | Citigroup | Buy | Buy | Maintains |
| 2019-01-03 | Deutsche Bank | Hold | Initiate | |
| 2018-11-14 | Citigroup | Buy | Buy | Maintains |
| 2018-08-01 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2018-07-31 | Jefferies | Buy | Buy | Maintains |
| 2018-07-31 | Credit Suisse | Neutral | Neutral | Maintains |
| 2018-02-23 | BMO Capital | Outperform | Outperform | Maintains |
| 2018-02-22 | Credit Suisse | Neutral | Neutral | Maintains |
| 2018-02-22 | Baird | Neutral | Neutral | Maintains |
| 2017-11-02 | Credit Suisse | Neutral | Initiate | |
| 2017-10-30 | Mizuho | Buy | Neutral | Downgrade |
| 2017-10-26 | BMO Capital | Outperform | Maintains | |
| 2017-10-25 | Cantor Fitzgerald | Neutral | Maintains | |
| 2017-10-25 | Baird | Outperform | Neutral | Downgrade |
| 2017-10-25 | Citigroup | Buy | Maintains | |
| 2017-10-25 | Bank of America | Buy | Maintains | |
| 2017-10-17 | BMO Capital | Outperform | Initiate | |
| 2017-07-31 | UBS | Buy | Maintains | |
| 2017-07-31 | Deutsche Bank | Buy | Maintains | |
| 2017-04-05 | Deutsche Bank | Buy | Initiate | |
| 2017-01-27 | Cantor Fitzgerald | Overweight | Neutral | Downgrade |
| 2017-01-04 | Citigroup | Buy | Initiate | |
| 2016-09-15 | Baird | Outperform | Maintains | |
| 2016-02-17 | Avondale Partners | Market Outperform | Maintains | |
| 2016-02-01 | KeyBanc | Overweight | Initiate | |
| 2015-09-16 | JP Morgan | Neutral | Initiate | |
| 2015-09-01 | Leerink Swann | Outperform | Initiate | |
| 2015-06-19 | Mizuho | Buy | Initiate | |
| 2015-05-21 | Susquehanna | Positive | Maintains | |
| 2015-04-30 | Deutsche Bank | Buy | Maintains | |
| 2015-04-30 | Jefferies | Buy | Maintains | |
| 2015-04-30 | Cantor Fitzgerald | Buy | Maintains | |
| 2015-04-30 | Wells Fargo | Market Perform | Outperform | Upgrade |
| 2015-02-17 | Citigroup | Neutral | Maintains | |
| 2014-10-31 | Deutsche Bank | Hold | Buy | Upgrade |
| 2014-10-30 | Jefferies | Buy | Maintains | |
| 2014-10-22 | UBS | Buy | Initiate | |
| 2014-06-04 | Raymond James | Outperform | Maintains | |
| 2014-02-21 | Bank of America | Buy | Maintains | |
| 2014-01-07 | Citigroup | Buy | Neutral | Downgrade |
| 2013-12-16 | Bank of America | Buy | Maintains | |
| 2013-12-06 | Wells Fargo | Market Perform | Initiate | |
| 2013-10-31 | Deutsche Bank | Hold | Maintains | |
| 2013-10-31 | BMO Capital | Outperform | Maintains | |
| 2013-04-05 | Bank of America | Buy | Maintains | |
| 2013-03-21 | Deutsche Bank | Hold | Maintains | |
| 2013-03-12 | Canaccord Genuity | Buy | Initiate | |
| 2013-02-22 | BMO Capital | Outperform | Maintains | |
| 2013-01-15 | Jefferies | Buy | Maintains | |
| 2012-12-10 | Deutsche Bank | Hold | Maintains | |
| 2012-11-08 | Deutsche Bank | Hold | Maintains | |
| 2012-11-08 | BMO Capital | Outperform | Maintains | |
| 2012-09-13 | Imperial Capital | Outperform | Maintains | |
| 2012-09-04 | Citigroup | Buy | Maintains | |
| 2012-09-04 | Jefferies | Buy | Maintains | |
| 2012-07-18 | Deutsche Bank | Buy | Hold | Downgrade |
| 2025-05-14 | Keybanc | Overweight | Overweight | Maintains |
| 2025-08-07 | UBS | Buy | Buy | Maintains |
| 2025-08-07 | Guggenheim | Buy | Buy | Maintains |
| 2025-08-07 | Barclays | Equal-Weight | Equal-Weight | Maintains |
